Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1919 1
1936 1
1938 1
1945 1
1947 1
1954 1
1959 1
1960 1
1961 1
1964 1
1968 1
1969 1
1970 1
1978 1
1983 2
1984 5
1985 6
1986 10
1987 4
1988 6
1989 4
1990 5
1991 3
1993 2
1995 1
1996 3
1997 2
1998 6
1999 15
2000 3
2001 4
2002 2
2003 1
2004 2
2005 3
2006 2
2007 3
2008 7
2009 7
2010 13
2011 6
2012 8
2013 6
2014 9
2015 7
2016 9
2017 8
2018 6
2019 9
2020 5
2021 4
2022 3
2023 5
2024 5
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
Stage au Gabon, une expérience de formation hors du commun.
Besson C, Brilhaut M, Bristot A, Deau A, Deandrade J, Phulpin J, Talbot G. Besson C, et al. Among authors: talbot g. Rev Infirm. 2017 Mar;66(229):51-52. doi: 10.1016/j.revinf.2016.12.036. Rev Infirm. 2017. PMID: 28284413 French. No abstract available.
Achromobacter xylosoxidans bacteremia.
McGann KA, Provencher M, Hoegg C, Talbot GH. McGann KA, et al. Among authors: talbot gh. Infect Control Hosp Epidemiol. 1990 Oct;11(10):539-41. doi: 10.1086/646088. Infect Control Hosp Epidemiol. 1990. PMID: 2230043 Review. No abstract available.
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study.
Tivey A, Shotton R, Eyre TA, Lewis D, Stanton L, Allchin R, Walter H, Miall F, Zhao R, Santarsieri A, McCulloch R, Bishton M, Beech A, Willimott V, Fowler N, Bedford C, Goddard J, Protheroe S, Everden A, Tucker D, Wright J, Dukka V, Reeve M, Paneesha S, Prahladan M, Hodson A, Qureshi I, Koppana M, Owen M, Ediriwickrema K, Marr H, Wilson J, Lambert J, Wrench D, Burney C, Knott C, Talbot G, Gibb A, Lord A, Jackson B, Stern S, Sutton T, Webb A, Wilson M, Thomas N, Norman J, Davies E, Lowry L, Maddox J, Phillips N, Crosbie N, Flont M, Nga E, Virchis A, Camacho RG, Swe W, Pillai A, Rees C, Bailey J, Jones S, Smith S, Sharpley F, Hildyard C, Mohamedbhai S, Nicholson T, Moule S, Chaturvedi A, Linton K. Tivey A, et al. Among authors: talbot g. Blood Adv. 2024 Mar 12;8(5):1209-1219. doi: 10.1182/bloodadvances.2023011152. Blood Adv. 2024. PMID: 38127279 Free PMC article.
A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial.
Cook JA, Patten PEM, Peckham N, Moss P, Phillips N, Abhishek A, Roberts T, Hodges M, Talbot G, Barber V, Francis A, Shields AM, Duley L, Hoogeboom R, Willett BJ, Scott S, Parry-Jones N, Eyre TA, Plested G, Vandici G, Wandroo FA, Hutchinson C, Paneesha S, Murray DJ, Martinez-Calle N, Jenkins S, Heartin E, Parry HM. Cook JA, et al. Among authors: talbot g. Lancet Haematol. 2025 Apr;12(4):e294-e303. doi: 10.1016/S2352-3026(25)00008-0. Lancet Haematol. 2025. PMID: 40175001 Free article. Clinical Trial.
207 results